Publications
-
Nabbout R, Arzimanoglou A, Auvin S, Berquin P, Desurkar A, Fuller D, Nortvedt C, Pulitano P, Rosati A, Soto V, Villanueva V and Cross JH.
Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY . 110: 78-85. Number of citations: 13
-
Cerulli Irelli E, Cocchi E, Ramantani G, Morano A, Riva A, Caraballo RH, Giuliano L, Yilmaz T, Panagiotakaki E, Operto FF, Giraldez BG, Balestrini S, Silvennoinen K, Casciato S, Comajuan M, Fortunato F, Giallonardo AT, Gamirova R, Coppola A, Di Gennaro G, Labate A, Sofia V, Kluger GJ, Gambardella A, Kasteleijn-Nolst Trenite D, Baykan B, Sisodiya SM, Arzimanoglou A, Striano P and Di Bonaventura C.
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia
EPILEPSIA . 64(6): 105-111. Number of citations: 5
-
Sourbron, J, Auvin, S, Arzimanoglou A, Cross, JH, Hartmann, H, Pressler, R, Riney, K, Sugai, K, Wilmshurst, JM, Yozawitz, E and Lagae, L.
Medical treatment in infants and young children with epilepsy: Off-label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children
Epilepsia Open . 8(1): 77-89. Number of citations: 17
-
Henshall DC, Arzimanoglou A, Dedeurwaerdere S, Guerrini R, Jozwiak S, Kokaia M, Lerche H, Pitkänen A, Ryvlin P, Simonato M and Sisodiya SM.
Shaping the future of European epilepsy research: Final meeting report from EPICLUSTER
EPILEPSY RESEARCH . 189: 107068-107068. Number of citations: 1
-
Brunklaus A, Brünger T, Feng T, Fons-Estupina C, Lehikoinen A, Panagiotakaki E, Vintan MA, Symonds J, Andrew J, Arzimanoglou A, Delima S, Gallois J, Hanrahan D, Lesca G, MacLeod S, Marjanovic D, McTague A, Nuñez-Enamorado N, Perez-Palma E, Scott Perry M, Pysden K, Russ-Hall SJ, Scheffer IE, Sully K, Syrbe S, Vaher U, Velayutham M, Vogt J, Weiss S, Wirrell E, Zuberi SM, Lal D, Møller RS, Mantegazza M and Cestèle S.
The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications
BRAIN . 145(11): 3816-3831. Number of citations: 108
-
Chávez López EK, Aparicio J, Carlos Valera Dávila, Campistol-Plana J, Ramírez-Camacho A, Fons-Estupina C and Arzimanoglou A.
Pre-surgical evaluation challenges and long-term outcome in children operated on for Low Grade Epilepsy Associated brain Tumors
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY . 41: 55-62. Number of citations: 3
-
Blumcke, I, Biesel, E, Bedenlier, S, Handel, M, Wilmshurst, J, Mehndiratta, MM, Yacubian, EM, Cendes, F, Arzimanoglou A, Beniczky, S, Wolf, P, Giavasi, C, Baxendale, S, Shisler, P and Wiebe, S.
A structured, blended learning program towards proficiency in epileptology: the launch of the ILAE Academy Level 2 Program
EPILEPTIC DISORDERS . 24(5): 737-750. Number of citations: 11
-
Martinez-Esteve Melnikova A, Pijuan-Marquilles J, Aparicio J, Ramírez-Camacho A, Altisent A, Vilanova-Adell A, Arzimanoglou A, Armstrong-Moron J, Palau F, Hoenicka J and San Antonio-Arce MV.
The p.Glu787Lys variant in the GRIA3 gene causes developmental and epileptic encephalopathy mimicking structural epilepsy in a female patient
European Journal of Medical Genetics . 65(3): 104442-104442. Number of citations: 5
-
Arzimanoglou A, Pringsheim, M, Kluger, GJ, Genton, P, Perdomo, C and Malhotra, M.
Safety and efficacy of rufinamide in children and adults with Lennox- Gastaut syndrome: A post hoc analysis from Study 022
EPILEPSY & BEHAVIOR . 124: . Number of citations: 5
-
Balestrini, S, Arzimanoglou A, Blumcke, I, Scheffer, IE, Wiebe, S, Zelano, J and Walker, MC.
The aetiologies of epilepsy
EPILEPTIC DISORDERS . 23(1): 1-16. Number of citations: 82